140 related articles for article (PubMed ID: 8971080)
1. A stable isotope dilution assay for the in vivo determination of insulin levels in humans by mass spectrometry.
Stöcklin R; Vu L; Vadas L; Cerini F; Kippen AD; Offord RE; Rose K
Diabetes; 1997 Jan; 46(1):44-50. PubMed ID: 8971080
[TBL] [Abstract][Full Text] [Related]
2. Development of an isotope dilution assay for precise determination of insulin, C-peptide, and proinsulin levels in non-diabetic and type II diabetic individuals with comparison to immunoassay.
Kippen AD; Cerini F; Vadas L; Stöcklin R; Vu L; Offord RE; Rose K
J Biol Chem; 1997 May; 272(19):12513-22. PubMed ID: 9139702
[TBL] [Abstract][Full Text] [Related]
3. A stable isotope method for in vivo assessment of human insulin synthesis and secretion.
Jainandunsing S; van Miert JNI; Rietveld T; Darcos Wattimena JL; Sijbrands EJG; de Rooij FWM
Acta Diabetol; 2016 Dec; 53(6):935-944. PubMed ID: 27552831
[TBL] [Abstract][Full Text] [Related]
4. Development of a liquid chromatographic time-of-flight mass spectrometric method for the determination of unlabelled and deuterium-labelled alpha-tocopherol in blood components.
Hall WL; Jeanes YM; Pugh J; Lodge JK
Rapid Commun Mass Spectrom; 2003; 17(24):2797-803. PubMed ID: 14673829
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of asymmetric and symmetric dimethylarginine, L-monomethylarginine, L-arginine, and L-homoarginine in biological samples using stable isotope dilution liquid chromatography tandem mass spectrometry.
Davids M; Swieringa E; Palm F; Smith DE; Smulders YM; Scheffer PG; Blom HJ; Teerlink T
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 900():38-47. PubMed ID: 22682940
[TBL] [Abstract][Full Text] [Related]
6. Insulins in equine urine: qualitative analysis by immunoaffinity purification and liquid chromatography/tandem mass spectrometry for doping control purposes in horse-racing.
Kuuranne T; Thomas A; Leinonen A; Delahaut P; Bosseloir A; Schänzer W; Thevis M
Rapid Commun Mass Spectrom; 2008; 22(3):355-62. PubMed ID: 18181226
[TBL] [Abstract][Full Text] [Related]
7. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
Vilsbøll T; Krarup T; Madsbad S; Holst JJ
Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
[TBL] [Abstract][Full Text] [Related]
8. Determination of amino acid isotope enrichment using liquid chromatography-mass spectrometry.
van Eijk HM; Rooyakkers DR; Soeters PB; Deutz NE
Anal Biochem; 1999 Jun; 271(1):8-17. PubMed ID: 10360999
[TBL] [Abstract][Full Text] [Related]
9. Dual microcolumn immunoassay applied to determination of insulin secretion from single islets of Langerhans and insulin in serum.
Shen H; Aspinwall CA; Kennedy RT
J Chromatogr B Biomed Sci Appl; 1997 Feb; 689(2):295-303. PubMed ID: 9080314
[TBL] [Abstract][Full Text] [Related]
10. Intracellular hyperinsulinism: a metabolic characteristic of obesity with and without Type 2 diabetes: intracellular insulin in obesity and Type 2 diabetes.
Benzi L; Ciccarone AM; Cecchetti P; DiCianni G; Caricato F; Trincavelli L; Volpe L; Navalesi R
Diabetes Res Clin Pract; 1999 Dec; 46(3):231-7. PubMed ID: 10624789
[TBL] [Abstract][Full Text] [Related]
11. Insulin action and secretion in healthy, glucose tolerant first degree relatives of patients with type 2 diabetes mellitus. Influence of body weight.
Volk A; Renn W; Overkamp D; Mehnert B; Maerker E; Jacob S; Balletshofer B; Häring HU; Rett K
Exp Clin Endocrinol Diabetes; 1999; 107(2):140-7. PubMed ID: 10320055
[TBL] [Abstract][Full Text] [Related]
12. Familial hyperinsulinemia associated with secretion of an abnormal insulin, and coexistence of insulin resistance in the propositus.
Vinik AI; Seino S; Funakoshi A; Schwartz J; Matsumoto M; Schteingart DE; Fu ZZ; Tsai ST
J Clin Endocrinol Metab; 1986 Apr; 62(4):645-52. PubMed ID: 3512591
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem mass spectrometry.
Guo T; Taylor RL; Singh RJ; Soldin SJ
Clin Chim Acta; 2006 Oct; 372(1-2):76-82. PubMed ID: 16707118
[TBL] [Abstract][Full Text] [Related]
14. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.
Meneilly GS; Elliott T
Diabetes Care; 1999 Jan; 22(1):112-8. PubMed ID: 10333911
[TBL] [Abstract][Full Text] [Related]
15. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.
Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L
Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756
[TBL] [Abstract][Full Text] [Related]
16. Procedure for determination of immunosuppressive drugs in whole blood with liquid chromatography-isotope dilution mass spectrometry.
Molnár PM; Dux L; Reinauer H; Kress M; Akerboom T; Szederkényi E; Kaiser P
Clin Lab; 2011; 57(11-12):983-92. PubMed ID: 22239031
[TBL] [Abstract][Full Text] [Related]
17. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
18. Effects of obesity, hyperinsulinemia, and glucose intolerance on insulin action in adipose tissue of sixty-year-old men.
Bolinder J; Lithell H; Skarfors E; Arner P
Diabetes; 1986 Mar; 35(3):282-90. PubMed ID: 3512339
[TBL] [Abstract][Full Text] [Related]
19. Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients.
Muscelli E; Mari A; Casolaro A; Camastra S; Seghieri G; Gastaldelli A; Holst JJ; Ferrannini E
Diabetes; 2008 May; 57(5):1340-8. PubMed ID: 18162504
[TBL] [Abstract][Full Text] [Related]
20. Determination of 17-hydroxyprogesterone in plasma by stable isotope dilution/benchtop liquid chromatography-tandem mass spectrometry.
Wudy SA; Hartmann M; Svoboda M
Horm Res; 2000; 53(2):68-71. PubMed ID: 10971091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]